Argentina Increases Tobacco Tax, Leading to Price Hike on Brands

Regulations by 2FIRSTS.ai

Jul.17.2024

Argentina Increases Tobacco Tax, Leading to Price Hike on Brands

Tobacco prices in Argentina have increased by 5-20% due to new tax policies affecting brands like Marlboro and Chesterfield.

According to LA ARENA reported on July 17, the newly implemented tobacco tax policy in Argentina resulted in a widespread increase in the prices of various cigarette brands over the weekend. The price hikes ranged from 5% to 20%, varying depending on the brand and packaging specifications. This price adjustment affected several well-known brands including Marlboro, Philip Morris, Chesterfield, and Harmony.

After receiving approval in the Basic Law, the Argentine government officially announced tax increase measures through General Resolution No. 5524/2024 in the official gazette. They have started implementing what is known as the "cigarette internal and additional emergency tax". This tax adjustment came into effect last Saturday, the 13th, and according to the new policy, the additional emergency tax levied on cigarette sales is determined based on a 7% tax rate on the final retail price of every pack of cigarettes nationwide, without any deductions.

In terms of prices adjusted for each brand, the new Marlboro prices are as follows:

The Red Box 20 is priced at $3.620, the Red KS 20 is priced at $3.190, the Red Box 12 is priced at $2.170, the Blue Coral Purple XL Box 20 is priced at $3.470, and the Vista Limited Edition Box 20 is also priced at $3.470.

Philip Morris brand price adjustment: Box of 20 priced at $3.010, KS 20 box priced at $2.660, Box of 12 priced at $1.790, Blue rotating box of 20 priced at $3.040, Random blue rotating box of 12 priced at $1.820.

References:

[1] Nueva suba en el precio de los cigarrillos

Also Read:

[1] Argentina's New Cigarette Tax System: Increased Efficiency and Transparency

[2] Man Arrested for Smuggling E-cigarettes in Argentina without Permission

[3] Controversy over Tobacco Tax Amendment in Argentine National Congress

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

SKE’s Parent Company Yinghe Technology Reports 80% Drop in Q3 Net Profit, Revenue Up 22.85% Year-on-Year

Yinghe Technology (SZ: 300457), parent company of SKE, saw Q3 net profit plunge 80.3% to 31.06 million yuan, while revenue rose 22.85% to 2.52 billion yuan. The decline was mainly driven by higher costs and expenses.

Oct.28 by 2FIRSTS.ai

Philip Morris International Restructures to Drive Its Smoke-Free Transformation

Philip Morris International (PMI) announced a new organizational model effective January 1, 2026, creating two main business units — PMI International and PMI U.S. — to accelerate its smoke-free strategy. The restructuring replaces four regional segments with three: International Smoke-Free, International Combustibles, and U.S., enhancing agility, governance, and long-term growth in reduced-risk products.

Nov.05 by 2FIRSTS.ai

South Korea Implements Law Requiring Full Disclosure of Tobacco Harmful Substances

South Korea has enacted the Tobacco Harm Management Act, effective November 1, 2025, requiring tobacco manufacturers and importers to test and report harmful substances in their products every two years. Results for all tobacco types—including combustible cigarettes, heated tobacco, and e-cigarettes—will be publicly available from mid-2026.